PIMCO Closed-End Funds Declare Monthly Common Share

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PIMCO Closed-End Funds Declare Monthly Common Share Distributions

NEW YORK, NY--(Marketwired - Jan 4, 2016) -  The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable on February 1, 2016 to shareholders of record on January 14, 2016, with an ex-dividend date of January 12, 2016.

     
Fund NYSE Symbol Monthly Distribution Per Share
PIMCO Corporate & Income Strategy Fund (NYSE: PCN) $ 0.112500
PIMCO Corporate & Income Opportunity Fund (NYSE: PTY) $ 0.130000
PIMCO Global StocksPLUS® & Income Fund (NYSE: PGP) $ 0.183350
PIMCO High Income Fund (NYSE: PHK) $ 0.103460
PIMCO Income Opportunity Fund (NYSE: PKO) $ 0.190000
PIMCO Strategic Income Fund, Inc. (NYSE: RCS) $ 0.080000
PCM Fund, Inc. (NYSE: PCM) $ 0.080000
PIMCO Income Strategy Fund (NYSE: PFL) $ 0.090000
PIMCO Income Strategy Fund II (NYSE: PFN) $ 0.080000
PIMCO Dynamic Income Fund (NYSE: PDI) $ 0.220500
PIMCO Dynamic Credit Income Fund (NYSE: PCI) $ 0.164063
PIMCO Municipal Income Fund (NYSE: PMF) $ 0.081250
PIMCO California Municipal Income Fund (NYSE: PCQ) $ 0.077000
PIMCO New York Municipal Income Fund (NYSE: PNF) $ 0.057000
PIMCO Municipal Income Fund II (NYSE: PML) $ 0.065000
PIMCO California Municipal Income Fund II (NYSE: PCK) $ 0.053750
PIMCO New York Municipal Income Fund II (NYSE: PNI) $ 0.066250
PIMCO Municipal Income Fund III (NYSE: PMX) $ 0.062300
PIMCO California Municipal Income Fund III (NYSE: PZC) $ 0.060000
PIMCO New York Municipal Income Fund III (NYSE: PYN) $ 0.052500
     

Distributions from PMF, PML, PMX, PCQ, PCK, PZC, PNF, PNI and PYN are generally exempt from regular Federal income taxes. In addition, distributions from PCQ, PCK and PZC are also generally exempt from California state income taxes, and distributions from PNF, PNI and PYN are generally exempt from New York State and city income taxes. There can be no assurance that all distributions paid by these Funds will be exempt from federal income taxes or applicable state or local income taxes.

Distributions may include ordinary income, net capital gains and/or returns of capital. Generally, a return of capital occurs when the amount distributed by a Fund includes a portion of (or is comprised entirely of) your investment in the Fund in addition to (or rather than) your pro-rata portion of the Fund's net income or capital gains. A Fund's distributions in any period may be more or less than the net return earned by the Fund on its investments, and therefore should not be used as a measure of performance or confused with "yield" or "income." A return of capital is not taxable; rather it reduces a shareholder's tax basis in his or her shares of the Fund. If a Fund estimates that a portion of its distribution may be comprised of amounts from sources other than net investment income, such Fund will notify shareholders of the estimated composition of such distribution through a separate written notice. Such notices are provided for informational purposes only, and should not be used for tax reporting purposes. Final tax characteristics of all Fund distributions will be provided on Form 1099-DIV, which is mailed after the close of the calendar year.

A Fund's distribution rate may be affected by numerous factors, including changes in realized and projected market returns, Fund performance, and other factors. There can be no assurance that a change in market conditions or other factors will not result in a change in a Fund distribution rate at a future time. 

Certain Funds may engage in investment strategies, including the use of derivatives, to, among other things, generate current, distributable income without regard to possible declines in the Fund's net asset value. A Fund's income and gain-generating strategies, including certain derivatives strategies, may generate current income and gains for monthly distributions even in situations when the Fund has experienced a decline in net assets, including losses due to adverse changes in securities markets or the Fund's portfolio of investments, including derivatives. Consequently, common shareholders may receive distributions and owe tax at a time when their investment in the Fund has declined in value, which tax may be at ordinary income rates. Also, the tax treatment of certain derivatives may be open to different interpretations. Any recharacterization of payments made or received by a Fund pursuant to derivatives potentially could affect the amount, timing or character of Fund distributions. In addition, the tax treatment of such investment strategies may be changed by regulation or otherwise.

The Funds' daily New York Stock Exchange closing market prices, net asset values per share, as well as other information, including updated portfolio statistics and performance are available at pimco.com/closedendfunds or by calling the Funds' shareholder servicing agent at (844) 33-PIMCO. Updated portfolio holdings information about a Fund will be available approximately 15 calendar days after such Fund's most recent fiscal quarter end, and will remain accessible until such Fund files a Form N-Q or a shareholder report for the period which includes the date of the information.

About PIMCO

PIMCO is a leading global investment management firm with offices in 12 countries throughout North America, Europe and Asia. Founded in 1971, PIMCO offers a wide range of innovative solutions to help millions of investors worldwide meet their needs. Our goal is to provide attractive returns while maintaining a strong culture of risk management and long-term discipline. PIMCO is the investment manager of the Funds' and is owned by Allianz S.E., a leading global diversified financial services provider.

Except for the historical information and discussions contained herein, statements contained in this news release constitute forward-looking statements. These statements may involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including the performance of financial markets, the investment performance of PIMCO's sponsored investment products and separately managed accounts, general economic conditions, future acquisitions, competitive conditions and government regulations, including changes in tax laws. Readers should carefully consider such factors. Further, such forward-looking statements speak only on the date at which such statements are made. PIMCO undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statement.

This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. PIMCO and YOUR GLOBAL INVESTMENT AUTHORITY are trademarks or registered trademarks of Allianz Asset Management of America L.P. and Pacific Investment Management Company LLC, respectively, in the United States and throughout the world. ©2016, PIMCO

For information on PIMCO Closed-end Funds: Financial Advisors: (800) 628-1237 Shareholders: (844) 337-4626 or (844) 33-PIMCO PIMCO Media Relations: (212) 739-4212

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 81

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 95

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 231

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 84

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 184

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 106

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 233

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Wynn Resorts Shares Insights on Fourth Quarter Financials

Updated Category News Views 148

Wynn Resorts Financial Results Announcement Wynn Resorts, Limited (NASDAQ: WYNN) has announced the upcoming financial results for the fourth quarter. Investors and stakeholders eagerly await this significant event, typically seen as a marker of the company’s performance over the holiday season and other vital periods. Date and Time of the Earnings Release The earnings...

Continue Reading
Understanding the Trust Crisis Plaguing AI Projects Today

Updated Category News Views 186

Trust Issues in AI: An Unveiling Survey In an era where artificial intelligence continues to transform industries, a recent survey sheds light on a pressing issue: trust in the content produced by AI. Conducted in early 2025, this survey dives into the concerns of various executives and knowledge managers, painting a vivid picture of the challenges that lie ahead for AI...

Continue Reading
NXP Semiconductors Declares Upcoming Dividend Payments

Updated Category News Views 125

NXP Semiconductors Declares Upcoming Dividend Payments NXP Semiconductors N.V. has recently taken a significant step in its capital return program by announcing an interim dividend. This decision reflects the company's robust capital structure and the board's unwavering confidence in its long-term growth potential. Details of the Interim Dividend Announcement The board...

Continue Reading
Empowering Patients: Shaping the Future of Rare Disease Treatment

Updated Category News Views 89

Empowering Patients in Rare Disease Drug Development This insightful webinar illuminates the pivotal role of patient-led organizations in the scientific and regulatory processes driving the development of therapies for ultra-rare diseases. By sharing their experiences and initiatives, speakers will provide a real-world context on how patient involvement has been...

Continue Reading
Upcoming Conference Call: Data Storage Corporation Insights

Updated Category News Views 96

Data Storage Corporation to Host Business Update Conference Call Data Storage Corporation (Nasdaq: DTST), a leading provider of innovative solutions, has scheduled an important conference call to discuss its progress and financial outcomes for the second quarter of the fiscal year 2025. This call is set for 11:00 a.m. Eastern Time on Thursday, August 14, 2025, marking a...

Continue Reading